June 28, 2022
What’s Changing: Blue Cross and Blue Shield of Montana (BCBSMT) is changing prior authorization requirements that may apply to some commercial members, to reflect new, replaced or removed codes due to updates from Utilization Management or the American Medical Association (AMA). A summary of changes is included below.
Important Reminder: Always check eligibility and benefits first through the Availity® Provider Portal or your preferred vendor portal, prior to rendering services. This step will confirm prior authorization requirements and utilization management vendors, if applicable.
- Oct. 1, 2022 – Addition of Molecular Genetic Lab Testing codes to be reviewed by AIM
- Oct. 1, 2022 – Addition and replacement of Medical Oncology drugs to be reviewed by AIM
- Oct. 1, 2022 – Addition of Specialty Pharmacy codes to be reviewed by BCBSMT
More Information: For a revised list of codes go to the Predetermination and Preauthorization section of our provider website.
CPT copyright 2021 American Medical Association (AMA). All rights reserved. CPT is a registered trademark of the AMA.
Checking eligibility and/or benefit information and/or obtaining prior authorization is not a guarantee of payment. Benefits will be determined once a claim is received and will be based upon, among other things, the member’s eligibility and the terms of the member’s certificate of coverage, including, but not limited to, exclusions and limitations applicable on the date services were rendered. If you have any questions, call the number on the member's ID card.
AIM Specialty Health (AIM) is an independent company that has contracted with BCBSMT to provide utilization management services for members with coverage through BCBSMT.
Availity is a trademark of Availity, LLC, a separate company that operates a health information network to provide electronic information exchange services to medical professionals. Availity provides administrative services to BCBSMT.